SARS-CoV-2, long COVID, prion disease and neurodegeneration

Yuhai Zhao; Vivian R Jaber; Walter J Lukiw

doi:10.3389/fnins.2022.1002770

SARS-CoV-2, long COVID, prion disease and neurodegeneration

Front Neurosci. 2022 Sep 27:16:1002770. doi: 10.3389/fnins.2022.1002770. eCollection 2022.

Authors

Yuhai Zhao^{1

2}, Vivian R Jaber², Walter J Lukiw^{2

3

4}

Affiliations

¹ Department of Cell Biology and Anatomy, Louisiana State University Health Sciences Center, New Orleans, LA, United States.
² LSU Neuroscience Center, LSU Health Sciences Center, New Orleans, LA, United States.
³ Department of Ophthalmology, LSU Health Sciences Center, New Orleans, LA, United States.
⁴ Department of Neurology, LSU Health Sciences Center, New Orleans, LA, United States.

No abstract available

Keywords: Alzheimer's disease (AD); Creutzfeldt-Jacob disease (CJD); SARS-CoV-2; long COVID-19; miRNA-146a; miRNA-155; prion disease (PrD); ‘S1’ spike protein.